Central Manchester University Hospitals NHS Foundation Trust, UK

Similar documents
The Centre for Disease Prevention and Control, Latvia

Hospital Carlos Haya. Malaga, Spain

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

National Center for Tumor Diseases (NCT) Heidelberg, Germany

Ministry for Health, the Elderly and Community Care, Malta

INSTITUTE OF CHILD HEALTH, Greece

European Society of Cardiology, France

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

Department of Medical Genetics, Medical School, University of Athens, Greece

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

Cystic Fibrosis Europe (CFE), Germany

Schoen Kliniken group, Schoen Klinik Hamburg Eilbek, Dept. of neurology and. neurorehabilitation, Germany

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

VSOP, Lupus Netherlands

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

European Reference Networks (ERN) Guide for patient advocates

European Haemophilia Consortium

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

ERN board of Member States

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

10 Specialist commissioning

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

JOB DESCRIPTION JOB DESCRIPTION

Commissioning Policy (WM12) Patients Changing Responsible Commissioner. Version 2 February 2012

European network of paediatric research (EnprEMA)

EPSRC-NIHR Healthcare Technology Cooperatives Partnership Awards

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

Dalton Review RCR Clinical Radiology Proposal Radiology in the UK the case for a new service model July 2014

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

Continuing Professional Development From an international perspective

European Reference Networks: strategic value for the Member States. Perspective of France

National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Presenting the European Investment Advisory Hub Annual Forum of the EUSDR, 2015 Ulm. European Investment Advisory Hub 1

The British Society of Haematology and NIHR Clinical Research Network Award scheme to recognise NHS consultants and trainees active in research

Summary of a Survey on the Europe 2020 Flagship Initiative Innovation Union. Executive Summary

Health Select Committee inquiry into Brexit and health and social care

Freedom of Information Act 2000

Amending the Certificate of Current Professional Status template

European Investment Advisory Hub

Simona Bovha, CPCM European Investment Bank. European Investment Advisory Hub

DRAFT 2. Specialised Paediatric Services in Scotland. 1 Specialised Services Definition

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

QUICK REFERENCE TO CALDICOTT & THE DATA PROTECTION ACT 1998 PRINCIPLES

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

FUNDING NATURAL HERITAGE PROJECTS IN SCOTLAND LIFE+ NATURE AND BIODIVERISTY

NHS SCOTLAND APPLICATION FOR REIMBURSEMENT / PERMISSION TO TRAVEL FOR TREATMENT IN THE EUROPEAN ECONOMIC AREA

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Specialised Commissioning Oversight Group. Terms of Reference

NHS CANCER SERVICES FOR CHILDREN

Implementation Plan for the UK Strategy for Rare Diseases

National Research Ethics Service

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

Legal and financial issues Evaluation process

ERN Assessment Manual for Applicants

S2 and Directive routes: guidance for commissioners

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Report on the interim evaluation of the «Daphne III Programme »

Copernicus Incubation Programme

Background paper. Cross-border healthcare in the EU

ehealth in caring for people with multimorbidity in European countries

Introduction to ibmg. Marco Varkevisser Director of Education

A short paper for ENVI & IMCO MEPs Two solutions to improve recognition of specialisms in the Chapter III professions

116 Help Lines for Rare Diseases

Spreading Excellence and Widening Participation in Horizon 2020

CARE OF THE DYING IN THE NHS. The Buckinghamshire Communique 11 th March The Nuffield Trust

Jean Monnet support to associations


Building the Europe of Knowledge

Connecting Continents: Where now for Australian - European cooperation?

1. Outline the benefits bi-national working arrangements bring to the following:

APPENDIX ONE. ICAT: Integrated Clinical Assessment Tool

21 March NHS Providers ON THE DAY BRIEFING Page 1

EPF Workshops on Cross-Border Healthcare 1st Stop: Croatia Meeting Report

Equality and Diversity strategy

ANNEX I TO VIII ANNEX I. Health Programme Work Programme for 2017

The Seventh Framework Programme for candidate and potential candidate countries European Regional Economic Forum Nova Gorica, 30 May 2007

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure

European Investment Advisory Hub

Foundation in Paediatric Pharmaceutical Care 6th International Masterclass

EFQM Excellence Model

How to optimise research support and funding via the UKCRN

Council, 25 September 2014

Call for the expression of interest Selection of six model demonstrator regions to receive advisory support from the European Cluster Observatory

PAEDIATRIC CARDIOLOGY ST4

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

Document: Report on the work of the High Level Group in 2006

Supportive Care Roundtable

UK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division

Experience of inpatients with ulcerative colitis throughout

Info Session Webinar Joint Qualifications in Vocational Education and Training Call for proposals EACEA 27/ /10/2017

Trust Fellow (Equiv. ST5-8) in Paediatric Respiratory Medicine Paediatric Respiratory Medicine

FUNDING FOR TREATMENT IN THE EEA APPLICATION FORM

Delegations will find attached document EEAS 02246/8/14 REV 8.

JOB DESCRIPTION DIRECTOR OF SCREENING. Author: Dr Quentin Sandifer, Executive Director of Public Health Services and Medical Director

Transcription:

Central Manchester University Hospitals NHS Foundation Trust, UK 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Healthcare provider organisations (e.g. hospitals association, specialised provider association) Please indicate level: National level organisation Please indicate for what the administration is responsible: 1.1.1. Other (please specify): 1.2 Please indicate the name of your organisation or centre: Central Manchester University Hospitals NHS Foundation Trust 1.3 Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: 1. Please indicate the number of EU Member States and EEA countries (rway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1. If need be, can we contact you by e-mail to obtain further information on your submission? 1..1 Please provide an e-mail address where we can contact you: john.wareing@cmft.nhs.uk UK 1 Yes 1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): 1.7 Please provide additional contact details if needed: John Wareing Associate Director, Strategic Development 0161 901 83

2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC). 2.1 How would you describe your organisation's knowledge of CoE and HSHC? 2.1.1 Space for further comments: 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) High Highly specialised healthcare provision Management and organisational aspects of highly specialized healthcare Professional performance, clinical practice, quality and safety of specialized healthcare 2.2.1. Space for further comments: 2.3 Is highly specialised healthcare a priority in your organisation's strategies and work plans? 2.3.1 Space for further comments: 2.. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Very high Medical/Surgical speciality Please specify: 2.. Has your organisation/centre been directly involved in the design or assessment of professional standards and criteria related with highly specialised healthcare? Genetics, Paediatric specialties eg epilepsy opinion 2..1 Please describe your role in such actions/projects: 2.6. Has your organisation been involved in projects/activities supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare?

2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? Yes 2.7.1 Space for further comments: 2.13. What is the scope of the network? 2.1. Which kind of network? 2.1.1 Space for further comments: 2.1. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, = very interested) 2.1.1 Space for further comments: 3. Proposed criteria for ERN (scope, general and specific criteria) 3.1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN 3.1.1. Need of highly specialised healthcare 3.1.1.1. Complexity of the diagnosis and treatment 3.1.1.2. High cost of treatment and resources 3.1.1.3. Need of advanced/highly specialised medical equipment or infrastructures 3.1.2. Need of particular concentration of expertise and resources

3.1.2.1. Rare expertise/need of concentration of cases 3.1.2.2. Low prevalence/incidence/number of cases 3.1.2.3. Evaluated experiences of Member States 3.1.3. Based on high-quality, accessible and cost-effective healthcare 3.1.3.1. Evidence of the safety and favourable risk-benefit analysis 3.1.3.2. Feasibility and evidence of the value and potential positive outcome (clinical) 3.1.. Do you recommend any additional criteria or option that would effectively address the issue? 3.1.. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria? 3.2. General criteria of the centres wishing to join a European Reference Network 3.2.1. Organisation and management 3.2.2. Patients empowerment and centered care 3.2.3. Patient care, clinical tools and health technology assessment 3.2.. Quality, patient safety and evaluation framework policies 3.2.. Business continuity, contingency planning and response capacity

3.2.6. Information systems, technology and e-health tools and applications 3.2.7. Overall framework and capacity for research and training 3.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 3.2.9. Do you recommend any additional option that would effectively address the issue? 3.2.9.1. Space for further comments: 3.3. Specific criteria regarding the areas of expertise 3.3.1. Competence, experience and good outcomes and care 3.3.2. Specific resources and organisation: 3.3.2.1. Human resources 3.3.2.2. Team/centre organisation 3.3.2.3. Structural conditions 3.3.2.. Specific equipment 3.3.2.. Presence and coordination with other required complementary units or services 3.3.3. Patient care pathways, protocols and clinical guidelines in the field of expertise 3.3.. External coordination, care management and follow-up of patients

3.3.. Research, training, health technology assessment in the field of expertise 3.3.6. Specific information systems 3 3.3.7. Do you recommend any additional criteria or option that would effectively address the issue? 3.3.7.1. Space for further comments: further comments